报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 4.97% | -20.99% | 82.72% | 57/129 | 4.79% | 迈瑞医疗 | 28.68% | 行业排名> |
2024-06-30 | 2.72% | -19.76% | 294.2% | 63/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
2024-03-31 | 0.69% | -34.91% | -92.36% | 84/129 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
2023-12-31 | 9.03% | 18.5% | 43.56% | 41/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
2023-09-30 | 6.29% | 6.07% | 85.55% | 50/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
2023-06-30 | 3.39% | 8.31% | 219.81% | 61/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
2023-03-31 | 1.06% | -22.06% | -86.09% | 83/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
2022-12-31 | 7.62% | 93.4% | 28.5% | 75/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
2022-09-30 | 5.93% | 30.04% | 89.46% | 80/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
2022-06-30 | 3.13% | 24.7% | 130.15% | 84/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
2022-03-31 | 1.36% | 32.04% | -65.48% | 77/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
2021-12-31 | 3.94% | -23.35% | -13.6% | 110/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
2021-09-30 | 4.56% | -19.43% | 81.67% | 93/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
2021-06-30 | 2.51% | -22.05% | 143.69% | 103/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
2021-03-31 | 1.03% | -11.21% | -79.96% | 87/129 | 6.23% | 热景生物 | 57.63% | 行业排名> |
2020-12-31 | 5.14% | -80.09% | -9.19% | 105/129 | 25.82% | 中红医疗 | 168% | 行业排名> |
2020-09-30 | 5.66% | -73.03% | 75.78% | 65/129 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
2020-06-30 | 3.22% | -77.99% | 177.59% | 85/129 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
2020-03-31 | 1.16% | 2% | -95.51% | 57/129 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
2019-12-31 | 25.81% | -19.04% | 22.96% | 24/129 | 14.38% | 健尔康 | 84.09% | 行业排名> |
2019-09-30 | 20.99% | 2% | 43.47% | 11/129 | 10.49% | 祥生医疗 | 28.56% | 行业排名> |
2019-06-30 | 14.63% | 2% | -54.11% | 7/129 | 6.73% | 心脉医疗 | 31.04% | 行业排名> |
2018-12-31 | 31.88% | 2% | 2% | 13/129 | 12.98% | 新华医疗 | 13.55% | 行业排名> |